Rishi Gupta's most recent trade in Turnstone Biologics Corp was a trade of 3,099,265 Common Stock done . Disclosure was reported to the exchange on Aug. 8, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnstone Biologics Corp | Rishi Gupta | Director | 08 Aug 2025 | 3,099,265 | 0 | - | - | Common Stock | ||
| Enliven Therapeutics Inc | Rishi Gupta | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 20,491 | 20,491 | - | - | Stock Option (right to buy) | |
| Turnstone Biologics Corp | Rishi Gupta | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 12,770 | 12,770 | - | - | Stock Option (Right to Buy) | |
| Enliven Therapeutics Inc | Rishi Gupta | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 22.14 per share. | 16 May 2024 | 1,000,000 | 7,663,349 | - | 22.1 | 22,140,000 | Common Stock |
| Enliven Therapeutics Inc | Rishi Gupta | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 22.14 per share. | 16 May 2024 | 33,300 | 254,814 | - | 22.1 | 737,262 | Common Stock |
| Enliven Therapeutics Inc | Rishi Gupta | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 23,364 | 23,364 | - | - | Stock Option (right to buy) | |
| Turnstone Biologics Corp | Rishi Gupta | Director, Ten Percent Owner | 20 Jul 2023 | 2,682,599 | 2,682,599 | - | - | Common Stock | ||
| Turnstone Biologics Corp | Rishi Gupta | Director, Ten Percent Owner | 20 Jul 2023 | 1,249,829 | 0 | - | - | Series B-2 Preferred Stock | ||
| Turnstone Biologics Corp | Rishi Gupta | Director, Ten Percent Owner | 20 Jul 2023 | 937,372 | 0 | - | - | Series B-1 Preferred Stock | ||
| Turnstone Biologics Corp | Rishi Gupta | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 12.00 per share. | 20 Jul 2023 | 416,666 | 3,099,265 | - | 12 | 4,999,992 | Common Stock |
| Turnstone Biologics Corp | Rishi Gupta | Director, Ten Percent Owner | 20 Jul 2023 | 266,240 | 0 | - | - | Series C Preferred Stock | ||
| Turnstone Biologics Corp | Rishi Gupta | Director, Ten Percent Owner | 20 Jul 2023 | 229,158 | 0 | - | - | Series D Preferred Stock | ||
| Enliven Therapeutics Inc | Rishi Gupta | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2023 | 2,125 | 0 | - | - | Stock Options (Right to Buy) | |
| Enliven Therapeutics Inc | Rishi Gupta | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.28 per share. | 17 May 2023 | 2,125 | 8,663,349 | - | 4.3 | 9,095 | Common Stock |
| Enliven Therapeutics Inc | Rishi Gupta | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 7,611,458 | 7,611,458 | - | - | Common Stock | |
| Enliven Therapeutics Inc | Rishi Gupta | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 288,114 | 288,114 | - | - | Common Stock | |
| Enliven Therapeutics Inc | Rishi Gupta | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 27,567 | 27,567 | - | - | Stock Option (right to buy) |